Cargando...
Cell wall inhibitors increase the accumulation of rifampicin in Mycobacterium tuberculosis
There is a need for new combination regimens for tuberculosis. Identifying synergistic drug combinations can avoid toxic side effects and reduce treatment times. Using a fluorescent rifampicin conjugate, we demonstrated that synergy between cell wall inhibitors and rifampicin was associated with inc...
Guardado en:
| Publicado en: | Access Microbiol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Microbiology Society
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7470358/ https://ncbi.nlm.nih.gov/pubmed/32974492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1099/acmi.0.000006 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|